124 related articles for article (PubMed ID: 38830145)
1. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
[TBL] [Abstract][Full Text] [Related]
2. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation?
Skowrońska M; Litwin T; Dzieżyc K; Wierzchowska A; Członkowska A
Neurol Neurochir Pol; 2013; 47(6):542-6. PubMed ID: 24374999
[TBL] [Abstract][Full Text] [Related]
3. Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
Dusek P; Lescinskij A; Ruzicka F; Acosta-Cabronero J; Bruha R; Sieger T; Hajek M; Dezortova M
Radiology; 2021 Jun; 299(3):662-672. PubMed ID: 33754827
[TBL] [Abstract][Full Text] [Related]
4. Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.
Lee JH; Gregory A; Hogarth P; Rogers C; Hayflick SJ
AJNR Am J Neuroradiol; 2018 Mar; 39(3):583-588. PubMed ID: 29371252
[TBL] [Abstract][Full Text] [Related]
5. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
[TBL] [Abstract][Full Text] [Related]
6. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
[No Abstract] [Full Text] [Related]
8. A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.
Zhou X; Xiao X; Li XH; Qin HL; Pu XY; Chen DB; Wu C; Feng L; Liang XL
J Neurol; 2020 Jun; 267(6):1643-1650. PubMed ID: 32060651
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
[TBL] [Abstract][Full Text] [Related]
11. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
12. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
[TBL] [Abstract][Full Text] [Related]
14. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.
Walter U; Krolikowski K; Tarnacka B; Benecke R; Czlonkowska A; Dressler D
Neurology; 2005 May; 64(10):1726-32. PubMed ID: 15911799
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.
Kalita J; Kumar V; Parashar V; Misra UK
Mol Neurobiol; 2021 Nov; 58(11):6020-6031. PubMed ID: 34435331
[TBL] [Abstract][Full Text] [Related]
16. Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging.
Wang D; Li YY; Luo JH; Li YH
Arch Gerontol Geriatr; 2014; 59(2):439-49. PubMed ID: 24820446
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
[TBL] [Abstract][Full Text] [Related]
18. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates of cerebral water diffusion in Wilson disease.
Favrole P; Chabriat H; Guichard JP; Woimant F
Neurology; 2006 Feb; 66(3):384-9. PubMed ID: 16476937
[TBL] [Abstract][Full Text] [Related]
20. Cortical pencil lining on SWI MRI in NBIA and healthy aging.
van der Weijden MCM; van Laar PJ; Lambrechts RA; Verbeek DS; Tijssen MAJ
BMC Neurol; 2019 Oct; 19(1):233. PubMed ID: 31607263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
